Replies to post #80001 on Rivulet Media Inc (fka RIVU)

[Meach2]

INCREDIBLE!!!

FROM YOUR ARTICLE!

BMSN, through its subsidiary Regen BioPharma, is the developer of HemaXellerate... a drug intended to heal damaged bone marrow - the first of up to as many as 30 drugs that Bio Matrix Scientific Group intends to begin development of, and then sell to a bigger pharma player once that drug is well into (or perhaps even past) Phase 1 trials and the odds of reaching the proverbial end-zone look good.

THIRTY DRUGS!?!!?

WOWWWWWWWWWWWW